Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$548,066
+$41,343 QoQ
Shares Held
2,158
+4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#1,576
of 2,126 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sachetta, LLC holds $1,910,793 across 12 Drug Manufacturers - General names. JNJ ranks #1 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,158 | $548,066 | |
| 2 | LLY |
ELI LILLY & Co
|
314 | $376,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,226 | $286,040 | |
| 4 | ABBV |
AbbVie Inc.
|
1,086 | $273,280 | |
| 5 | AMGN |
Amgen Inc
|
556 | $201,337 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
757 | $95,639 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
994 | $57,273 | |
| 8 | PFE |
Pfizer Inc
|
1,739 | $41,874 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $548,066 | 2,158 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $506,723 | 2,073 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $456,531 | 2,206 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,138,478 | 6,140 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $944,911 | 6,186 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,141,807 | 6,885 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,037,647 | 7,175 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,231,493 | 7,599 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $993,449 | 6,797 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,018,426 | 6,438 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,009,091 | 6,438 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||